We show here that pretreatment of TRAIL resistant B-CLL cells with either of two HDACis, Oxam, or TSA, renders cells susceptible to subsequent killing by recombinant TRAIL protein. Here, TNFSF10 is linked to B-cell chronic lymphocytic leukemia.